Table 2.
Human gene | Model | Mutation | Pancreatic phenotype | Cell line phenotype | References |
---|---|---|---|---|---|
BBS1 | Zebrafish | Bbs1-deficient | Increased β-cells mass and decreased α- and δ-cells cell types in early developmental stages | N/A | (157) |
BBS4 | Mouse Zebrafish Min6 cells |
Bbs4-/-
Downregulation of Bbs4 |
Mice: Islets size was not affected despite impaired glucose homeostasis and obesity onset. Insulin levels reported are either normal or increased Zebrafish: Increased β-cells mass and decreased α- and δ-cells cell types in early developmental stages |
Loss of first phase insulin release. Unstimulated Min6 lacked both insulin receptor isoforms (IR-A or IR-B) in the cilium, after insulin stimulation IR-A, but not IR-B, was recruited to the cilium | (143, 157, 158) |
BBS5, BBS7, BBS9 | Min6 cells | Downregulation of Bbs5, Bbs7, and Bbs9 | N/A | ~2-fold increase in insulin secretion | (159) |
BBS12 | Mouse | Bbs12-/- | Islets size and plasma insulin levels were not affected despite enhanced in vivo insulin sensitivity | N/A | (160) |
AMLS1 | Mouse Zebrafish β-TC-6 cells |
Amls1-/-
Downregulation of Amls1 |
Mice: Pancreatic hyperplasia, partial degranulation of β-cells and islets cysts Zebrafish: Decreased β-cells production, hyperinsulinemia and impaired glucose-stimulated insulin secretion |
Modest hypersecretory basal state in unstimulated cells, impaired glucose-stimulated insulin secretion and altered gene expression for signals downstream of glucose transport | (157, 161–163) |
AMLS1 | Mouse | Alms1L2131X/L2131X | Stunted cilia and loss of calcium signaling | N/A | (164) |
IFT88 | Mouse | Ift88/Polaris-/- | Loss of cilia in ductal and endocrine cells, cystogenesis, abnormal tubular structures, endocrine cells in duct, acinar cells apoptosis, endocrine islets normal except for increased β-cells clustering | N/A | (10, 130) |
KIF3A | Mouse Min6 cells |
Kif3a-/-
Downregulation of Kif3a |
Loss of cilia in ductal and endocrine cells, leading to acinar-to-ductal metaplasia, fibrosis, cyst formation, aberrant ductal cell morphology and lipomatosis | Decreased proliferation | (10, 165) |
HNF6 | Mouse | Hnf6-/- | Loss of ductal primary cilium, enlarged lumen and multiple cysts. Delayed Pdx1 expression and hypoplastic pancreas with retarded pancreatic specification of endodermal cells | N/A | (166–168) |
RFX3 | Mouse | Rfx3-/- | Reduced and stunned primary cilia. Reduced β-cells, α-cells, and δ-cells, increased pancreatic polypeptide-positive cells in perinatal stages. Adults showed small and disorganized islets, decreased insulin production, reduced glucose-stimulated insulin section, and impaired glucose tolerance | N/A | (155) |
LKB1/STK11 | Mouse | Lkb1-/- | Reduced β-cells, α-cells, and δ-cells number. Altered localization of cilia in β-cells and increased β-cells volume and insulin secretion in vivo with improved glucose tolerance | N/A | (169–172) |
IDE | Mouse INS1E cells Mouse |
Ide-/- in β-cells
Downregulation of Ide Ide-/- in α-cells |
B-IDE-KO: Impaired glucose-simulated insulin secretion. β-cell immaturity with constitutive insulin and pro-insulin secretion, decreased gene expression of Ins2, Ucn3, and Pcsk1, decreased GLUT2 plasma membrane levels A-IDE-KO: Impaired ciliogenesis, α-cells hyperplasia, and hypertrophy, impaired insulin inhibition of glucagon secretion, hyperglucagonemia and hyperinsulinemia, but normal glucose tolerance |
Impaired GSIS N/A |
(173, 174) (175) |